Cancer Letters

Cancer Letters is an international journal that considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine.

Publisher
Elsevier
Website
http://www.journals.elsevier.com/cancer-letters/
Impact factor
4.238 (2011)

Some content from Wikipedia, licensed under CC BY-SA

Oncology & Cancer

Malaria drug could make cancer treatments more effective

An existing malaria drug could improve the effectiveness of a new class of cancer therapies, called glutaminase inhibitors, if used in combination, researchers at Weill Cornell Medicine-Qatar (WCM-Q) discovered in a new study.

Oncology & Cancer

Cancer researchers publish new papers on ovarian cancer tumor growth

Two papers involving ovarian cancer research at the University of Notre Dame's Harper Cancer Research Institute (HCRI), one featuring new research and the other a review article, were published as cover stories in their respective ...

Oncology & Cancer

Team unveils new TGF-beta functions in liver cancer

Recent research results from the TGF-beta and cancer research group at the Bellvitge Biomedical Research Institute (IDIBELL) provide a better understanding of the role of the TGF-beta cytokine in liver cancer. The work, published ...

page 1 from 2